![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: VTI1A |
Gene summary for VTI1A |
![]() |
Gene information | Species | Human | Gene symbol | VTI1A | Gene ID | 143187 |
Gene name | vesicle transport through interaction with t-SNAREs 1A | |
Gene Alias | MMDS3 | |
Cytomap | 10q25.2 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | Q96AJ9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
143187 | VTI1A | CCI_1 | Human | Cervix | CC | 1.97e-11 | 1.07e+00 | 0.528 |
143187 | VTI1A | CCI_2 | Human | Cervix | CC | 1.25e-15 | 1.56e+00 | 0.5249 |
143187 | VTI1A | CCI_3 | Human | Cervix | CC | 3.89e-07 | 6.75e-01 | 0.516 |
143187 | VTI1A | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.97e-23 | -6.46e-01 | 0.0155 |
143187 | VTI1A | HTA11_2487_2000001011 | Human | Colorectum | SER | 1.04e-02 | -3.80e-01 | -0.1808 |
143187 | VTI1A | HTA11_347_2000001011 | Human | Colorectum | AD | 3.14e-04 | 4.15e-01 | -0.1954 |
143187 | VTI1A | HTA11_3361_2000001011 | Human | Colorectum | AD | 5.44e-04 | -3.74e-01 | -0.1207 |
143187 | VTI1A | HTA11_866_3004761011 | Human | Colorectum | AD | 1.85e-05 | -5.16e-01 | 0.096 |
143187 | VTI1A | HTA11_4255_2000001011 | Human | Colorectum | SER | 5.88e-05 | -5.31e-01 | 0.0446 |
143187 | VTI1A | HTA11_8622_2000001021 | Human | Colorectum | SER | 1.94e-04 | -7.18e-01 | 0.0528 |
143187 | VTI1A | HTA11_7696_3000711011 | Human | Colorectum | AD | 9.78e-07 | -3.72e-01 | 0.0674 |
143187 | VTI1A | HTA11_99999970781_79442 | Human | Colorectum | MSS | 2.19e-14 | -5.64e-01 | 0.294 |
143187 | VTI1A | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.77e-42 | 1.98e+00 | 0.281 |
143187 | VTI1A | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.04e-22 | -6.19e-01 | 0.3005 |
143187 | VTI1A | A001-C-207 | Human | Colorectum | FAP | 1.04e-02 | -3.71e-01 | 0.1278 |
143187 | VTI1A | A015-C-203 | Human | Colorectum | FAP | 7.29e-39 | -7.38e-01 | -0.1294 |
143187 | VTI1A | A015-C-204 | Human | Colorectum | FAP | 2.20e-07 | -4.83e-01 | -0.0228 |
143187 | VTI1A | A014-C-040 | Human | Colorectum | FAP | 2.28e-07 | -6.42e-01 | -0.1184 |
143187 | VTI1A | A002-C-201 | Human | Colorectum | FAP | 2.19e-12 | -5.31e-01 | 0.0324 |
143187 | VTI1A | A002-C-203 | Human | Colorectum | FAP | 4.26e-04 | -2.61e-01 | 0.2786 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000703431 | Oral cavity | NEOLP | vacuolar transport | 30/2005 | 157/18723 | 1.18e-03 | 8.72e-03 | 30 |
GO:009016121 | Oral cavity | NEOLP | Golgi ribbon formation | 6/2005 | 13/18723 | 1.32e-03 | 9.48e-03 | 6 |
GO:000703022 | Oral cavity | NEOLP | Golgi organization | 29/2005 | 157/18723 | 2.40e-03 | 1.53e-02 | 29 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa041305 | Esophagus | ESCC | SNARE interactions in vesicular transport | 28/4205 | 33/8465 | 2.75e-05 | 1.32e-04 | 6.75e-05 | 28 |
hsa0413012 | Esophagus | ESCC | SNARE interactions in vesicular transport | 28/4205 | 33/8465 | 2.75e-05 | 1.32e-04 | 6.75e-05 | 28 |
hsa041302 | Liver | HCC | SNARE interactions in vesicular transport | 25/4020 | 33/8465 | 8.78e-04 | 3.38e-03 | 1.88e-03 | 25 |
hsa041303 | Liver | HCC | SNARE interactions in vesicular transport | 25/4020 | 33/8465 | 8.78e-04 | 3.38e-03 | 1.88e-03 | 25 |
hsa041304 | Oral cavity | OSCC | SNARE interactions in vesicular transport | 28/3704 | 33/8465 | 1.31e-06 | 7.18e-06 | 3.66e-06 | 28 |
hsa0413011 | Oral cavity | OSCC | SNARE interactions in vesicular transport | 28/3704 | 33/8465 | 1.31e-06 | 7.18e-06 | 3.66e-06 | 28 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
VTI1A | SNV | Missense_Mutation | c.548N>T | p.Gly183Val | p.G183V | Q96AJ9 | protein_coding | deleterious(0.01) | benign(0.288) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
VTI1A | SNV | Missense_Mutation | rs746061602 | c.586G>A | p.Val196Ile | p.V196I | Q96AJ9 | protein_coding | tolerated(0.52) | benign(0.043) | TCGA-AY-6197-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
VTI1A | SNV | Missense_Mutation | novel | c.205A>G | p.Met69Val | p.M69V | Q96AJ9 | protein_coding | tolerated(0.06) | benign(0.049) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
VTI1A | SNV | Missense_Mutation | rs148949614 | c.389N>A | p.Arg130Gln | p.R130Q | Q96AJ9 | protein_coding | tolerated(0.06) | possibly_damaging(0.64) | TCGA-D5-6530-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
VTI1A | SNV | Missense_Mutation | c.548G>T | p.Gly183Val | p.G183V | Q96AJ9 | protein_coding | deleterious(0.01) | benign(0.288) | TCGA-WS-AB45-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
VTI1A | SNV | Missense_Mutation | rs770821310 | c.280N>A | p.Ala94Thr | p.A94T | Q96AJ9 | protein_coding | deleterious(0.05) | benign(0.061) | TCGA-A5-A0G2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
VTI1A | SNV | Missense_Mutation | rs770821310 | c.280N>A | p.Ala94Thr | p.A94T | Q96AJ9 | protein_coding | deleterious(0.05) | benign(0.061) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VTI1A | SNV | Missense_Mutation | novel | c.648N>C | p.Arg216Ser | p.R216S | Q96AJ9 | protein_coding | tolerated(0.05) | benign(0.001) | TCGA-AX-A1CE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unspecific | Paclitaxel | SD |
VTI1A | SNV | Missense_Mutation | novel | c.350N>T | p.His117Leu | p.H117L | Q96AJ9 | protein_coding | deleterious(0.02) | benign(0.011) | TCGA-5R-AAAM-01 | Liver | liver hepatocellular carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VTI1A | SNV | Missense_Mutation | c.479N>A | p.Ile160Lys | p.I160K | Q96AJ9 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-55-1592-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |